ARM suggests cross-border healthcare plan for ATMPs in Europe
The Alliance for Regenerative Medicine publishes a cross-border healthcare plan, which would enable ‘timely and effective’ access to ATMPs for patients in Europe.
The Alliance for Regenerative Medicine publishes a cross-border healthcare plan, which would enable ‘timely and effective’ access to ATMPs for patients in Europe.
J&J warns impact of biosimilar competition will ‘bleed into 2020’ after emerging from 2019 relatively unscathed.